Bevacizumab in combination with a taxane for the first-line treatment of metastatic breast cancer

Technology appraisal guidance
Reference number: TA214
Published: 23 February 2011

Breast cancer - bevacizumab (in combination with a taxane): response to consultee, commentator and public comments on the ACD and comments from website consultation

Breast cancer - bevacizumab (in combination with a taxane): response to consultee, commentator and public comments on the ACD and comments from website consultation

Breast cancer - bevacizumab (in combination with a taxane): response to consultee, commentator and public comments on the ACD and comments from website consultation
08 December 2010
(185.91 Kb 54 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 08 December 2010